William Blair analyst Margaret Kaczor reiterated an Outperform rating on ResMed (NYSE: RMD)The analyst comments: "Management believes there will be ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE